The Outbreak of Coronavirus Disease 2019 Interfered with Influenza in Wuhan

Zhou, Xianlong; Ding, Guoyong; Shu, Ting; Fu, Shouzhi; Tong, Weiwei; Tu, Xiaopeng; Li, Shunqing; Wu, Di; Yang, Qian; Yu, Jiangtao; Cao, Song; Jiang, Cheng; Ma, Hongwei; Li, Shaoping; Xia, Jian Chuan; Zhao, Zhiyuan; Peng, Zhiyong; Yua, Yuan; Mu, Yu; Li, Yirong; Li, Zhiqiang; Xing, Weijia; Zhou, Xi; Zhou, Yan

doi:10.2139/ssrn.3555239

Cited by 12 publications

(14 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Section: Discussionmentioning

confidence: 99%

“…SARS‐CoV‐2 can circulate in the environment with other microorganisms and can change with disease patterns 9 . The influenza epidemic in Wuhan, China, was interfered with by COVID‐19 emergence 9 . In a study analyzing two centers in China, the coinfection pattern differed significantly, and a large proportion of patients in Quindao had other seasonal respiratory pathogens in patients with COVID‐19 compared to Wuhan.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID‐19 and Mycoplasma pneumoniae in the USA

Gayam

Konala

Naramala

et al. 2020

Journal of Medical Virology

View full text Add to dashboard Cite

Coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) is spreading at a rapid pace, and the World Health Organization declared it as pandemic on 11 March 2020. Mycoplasma pneumoniae is an "atypical" bacterial pathogen commonly known to cause respiratory illness in humans. The coinfection from SARS‐CoV‐2 and mycoplasma pneumonia is rarely reported in the literature to the best of our knowledge. We present a study in which 6 of 350 patients confirmed with COVID‐19 were also diagnosed with M. pneumoniae infection. In this study, we described the clinical characteristics of patients with coinfection. Common symptoms at the onset of illness included fever (six [100%] patients); five (83.3%) patients had a cough, shortness of breath, and fatigue. The other symptoms were myalgia (66.6%), gastrointestinal symptoms (33.3%‐50%), and altered mental status (16.7%). The laboratory parameters include lymphopenia, elevated erythrocyte sedimentation rate, C‐reactive protein, lactate dehydrogenase, interleukin‐6, serum ferritin, and D‐dimer in all six (100%) patients. The chest X‐ray at presentation showed bilateral infiltrates in all the patients (100%). We also described electrocardiogram findings, complications, and treatment during hospitalization in detail. One patient died during the hospital course.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID‐19 and Mycoplasma pneumoniae in the USA

Gayam

Konala

Naramala

et al. 2020

Journal of Medical Virology

View full text Add to dashboard Cite

show abstract

“…There were 9 coinfection cases of influenza and COVID-19 reported in 1054 cases. 6 As per Centers for Disease Control and Prevention estimates from 2018-2019, approximately 35 million people were infected with influenza that resulted in approximately half million hospitalizations. Thirty-four thousand patients died from influenza last year.…”

Section: Discussionmentioning

confidence: 99%

A Case Series of Patients Coinfected With Influenza and COVID-19

Konala

Adapa

Naramala

et al. 2020

Journal of Investigative Medicine High Impact Case Reports

View full text Add to dashboard Cite

Coronavirus disease 2019, also called COVID-19, is a global pandemic resulting in significant morbidity and mortality worldwide. In the United States, influenza infection occurs mainly during winter and several factors influence the burden of the disease, including circulating virus characteristics, vaccine effectiveness that season, and the duration of the season. We present a case series of 3 patients with coinfection of COVID-19 and influenza, with 2 of them treated successfully and discharged home. We reviewed the literature of patients coinfected with both viruses and discussed the characteristics, as well as treatment options.

show abstract

“…While no official numbers exist as far as rates of influenza coinfection, review of the literature suggests that the rate ranges anywhere from 0.08 to 90%, depending on region. In a retrospective chart review performed by Zhou and Ding at a single hospital center in Wuhan, China, the authors found that nine out of 1054 (0.9%) patients who tested positive for Covid-19 also tested positive for influenza [ 5 ]. In another cohort of cases from the same region, 5 out of 115 (4.35%) patients who tested positive for Covid-19 also tested positive for influenza [ 6 ].…”

Section: Discussionmentioning

confidence: 99%

A case series of coinfection with SARS-CoV-2 and influenza virus in Louisiana

Miatech¹,

Tarte²,

Katragadda³

et al. 2020

Respiratory Medicine Case Reports

View full text Add to dashboard Cite

Severe acute respiratory syndrome coronavirus–2 (SARS-CoV-2) is the novel coronavirus initially detected in Wuhan, China, and is responsible for the worldwide pandemic coronavirus disease 2019 (Covid-19). Influenza is a common endemic respiratory virus that causes seasonal outbreaks of respiratory illness. There are currently few reports in the literature describing patients with coexisting infections. This case series of 4 patients identified at our single institution in Louisiana highlights the patient characteristics, laboratory findings, and outcomes in patients with both Covid-19 and influenza infection.

show abstract

The Outbreak of Coronavirus Disease 2019 Interfered with Influenza in Wuhan

Cited by 12 publications

References 0 publications

Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID‐19 and Mycoplasma pneumoniae in the USA

Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID‐19 and Mycoplasma pneumoniae in the USA

A Case Series of Patients Coinfected With Influenza and COVID-19

A case series of coinfection with SARS-CoV-2 and influenza virus in Louisiana

Contact Info

Product

Resources

About